NCT01444248View on ClinicalTrials.gov

Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

May 31, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Glimepiride/ Metformin

4/1000mg once daily

DRUG

Glimepiride/ Metformin

4/1000mg bid

Trial Locations (1)

Unknown

Handok Pharmaceuticals, Seoul

Sponsors

Lead Sponsor

Handok Inc.
All Listed Sponsors
lead

Handok Inc.

INDUSTRY

NCT01444248 - Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy | Biotech Hunter | Biotech Hunter